Introduction: microRNA (miRNA) levels are dysregulated in many cancers, suggesting that miRNA-based therapy may be effective. The molecular pathways of colorectal cancer (CRC) development are unknown.
Method: Understanding miRNAs implicated in CRC formation may reveal new diagnostic and therapeutic targets.